All Stories

  1. Genetic epidemiology of amyotrophic lateral sclerosis in Cyprus: a population-based study
  2. The FGF14 GAA repeat expansion is a major cause of ataxia in the Cypriot population
  3. Chemical Characterization and Assessment of the Neuroprotective Potential of Euphrasia officinalis
  4. Saponin and Phenolic Composition and Assessment of Biological Activities of Saponaria officinalis L. Root Extracts
  5. RFC1 Repeat Distribution in the Cypriot Population
  6. Two case reports of a novel missense mutation in the PNPLA6 gene in two siblings with chorioretinal dystrophy, hypogonadotropic hypogonadism, and cerebellar ataxia
  7. The influence of environmental risk factors in the development of ALS in the Mediterranean Island of Cyprus
  8. Chemical Profiling and Antioxidant and Anti-Amyloid Capacities of Salvia fruticosa Extracts from Greece
  9. Sideritis scardica Extracts Demonstrate Neuroprotective Activity against Aβ25–35 Toxicity
  10. Novel de novo DNMT1 gene mutation associated with hereditary sensory and autonomic neuropathy 1E (HSAN1E)
  11. The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p.P600R substitution causes demyelinating Charcot–Marie–Tooth disease
  12. Enrichr in silico analysis of MS-based extracted candidate proteomic biomarkers highlights pathogenic pathways in systemic sclerosis
  13. PathIN: an integrated tool for the visualization of pathway interaction networks
  14. ANO10 Function in Health and Disease
  15. Transcriptomic characterization of tissues from patients and subsequent pathway analyses reveal biological pathways that are implicated in spastic ataxia
  16. A Novel SPG7 Gene Pathogenic Variant in a Cypriot Family With Autosomal Recessive Spastic Ataxia
  17. Variant transthyretin amyloidosis (ATTRv) polyneuropathy in Greece: a broad overview with a focus on non-endemic unexplored regions of the country
  18. A Novel CLN6 Variant Associated With Juvenile Neuronal Ceroid Lipofuscinosis in Patients With Absence of Visual Loss as a Presenting Feature
  19. In depth analysis of Cyprus-specific mutations of SARS-CoV-2 strains using computational approaches
  20. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go
  21. Performance evaluation of pipelines for mapping, variant calling and interval padding, for the analysis of NGS germline panels
  22. A Framework for Efficient N-Way Interaction Testing in Case/Control Studies With Categorical Data
  23. Greek Sage Exhibits Neuroprotective Activity against Amyloid Beta-Induced Toxicity
  24. A novel SLC30A10 missense variant associated with parkinsonism and dystonia without hypermanganesemia
  25. Analyzing Gene Expression Profiles from Ataxia and Spasticity Phenotypes to Reveal Spastic Ataxia Related Pathways
  26. Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches
  27. Genetic Susceptibility to Systemic Sclerosis in the Greek-Cypriot Population: A Pilot Study
  28. Early-onset presentation of a new subtype of β-Propeller protein-associated neurodegeneration (BPAN) caused by a de novo WDR45 deletion in a 6 year-old female patient
  29. Risk factors for breast cancer brain metastases: a systematic review
  30. The frequency of central nervous system complications in the Cypriot cohort of ATTRV30M neuropathy transplanted patients
  31. Distal hereditary motor neuronopathy of the Jerash type is caused by a novel SIGMAR1 c.500A>T missense mutation
  32. PDXK mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementation
  33. Deregulation of LRSAM1 expression impairs the levels of TSG101, UBE2N, VPS28, MDM2 and EGFR
  34. Gene variants of adhesion molecules predispose to MS: A case-control study
  35. Revealing Clusters of Connected Pathways Through Multisource Data Integration in Huntington's Disease and Spastic Ataxia
  36. Epidemiology of ATTRV30M neuropathy in Cyprus and the modifier effect of complement C1q on the age of disease onset
  37. Biochemical Characterization of the GBA2 c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic Ataxia
  38. Quantification of dysarthrοphonia in a Cypriot family with autosomal recessive hereditary spastic paraplegia associated with a homozygous SPG11 mutation
  39. Epidemiology of Huntington disease in Cyprus: A 20-year retrospective study
  40. Gene variants of adhesion molecules act as modifiers of disease severity in MS
  41. Type 2 Diabetes Susceptibility in the Greek-Cypriot Population: Replication of Associations with TCF7L2, FTO, HHEX, SLC30A8 and IGF2BP2 Polymorphisms
  42. Genomic and genetic studies of systemic sclerosis: A systematic review
  43. Genetic findings of Cypriot spinal muscular atrophy patients
  44. Friedreich's ataxia and other hereditary ataxias in Greece: An 18-year perspective
  45. A NovelGBA2Gene Missense Mutation in Spastic Ataxia
  46. Molecular diagnosis of autosomal recessive cerebellar ataxia in the whole exome/genome sequencing era
  47. Advances in the molecular diagnosis of Charcot-Marie-Tooth disease
  48. Investigation of SCA10 in the Cypriot population: Further exclusion of SCA dynamic repeat mutations
  49. A novel LRSAM1 mutation is associated with autosomal dominant axonal Charcot-Marie-Tooth disease
  50. Huntington's disease in Greece: the experience of 14 years
  51. EMQN Best Practice Guidelines for molecular genetic testing of SCAs
  52. Charcot-Marie-Tooth Disease in Cyprus: Epidemiological, Clinical and Genetic Characteristics
  53. Absence of aprataxin gene mutations in a Greek cohort with sporadic early onset ataxia and normal GAA triplets in frataxin gene
  54. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met
  55. Familial Asymmetric Distal Upper Limb Amyotrophy (Hirayama Disease)
  56. Complete deletion of the aprataxin gene: ataxia with oculomotor apraxia type 1 with severe phenotype and cognitive deficit
  57. A novel ALS2 splice-site mutation in a Cypriot juvenile-onset primary lateral sclerosis family
  58. Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus
  59. Presymptomatic molecular diagnosis of autosomal dominant polycystic kidney disease using PKD1-and PKD2-linked markers in Cypriot families
  60. A novel c.5308_5311delGAGA mutation in Senataxin in a Cypriot family with an autosomal recessive cerebellar ataxia
  61. Auditory nerve is affected in one of two different point mutations of the neurofilament light gene
  62. Complete deletion of the aprataxin gene: ataxia with oculomotor apraxia type 1 with severe phenotype and cognitive deficit
  63. Malignant mutation in the lamin A/C gene causing progressive conduction system disease and early sudden death in a family with mild form of limb-girdle muscular dystrophy
  64. A Novel GDAP1 Mutation 439delA is Associated with Autosomal Recessive CMT Disease
  65. Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X
  66. The Cypriot and Iranian National Mutation Frequency Databases
  67. Absence of linkage to chromosomes 6q and 16p in a Greek population with knee osteoarthritis
  68. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations
  69. A novel PMP22 mutation Ser22Phe in a family with hereditary neuropathy with liability to pressure palsies and CMT1A phenotypes
  70. A gene for nonsyndromic X-linked mental retardation (MRX77) maps to Xq12-Xq21.33
  71. Glycyl tRNA Synthetase Mutations in Charcot-Marie-Tooth Disease Type 2D and Distal Spinal Muscular Atrophy Type V
  72. A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family
  73. Linkage of otosclerosis to a third locus (OTSC3) on human chromosome 6p21.3-22.3
  74. Mapping of the second Friedreich's ataxia (FRDAff2) locus to chromosome 9p23-p11: evidence for further locus heterogeneity
  75. A novel form of distal hereditary motor neuronopathy maps to chromosome 9p21.1–p12
  76. A novel form of distal hereditary motor neuronopathy maps to chromosome 9p21.1–p12
  77. Fundamental Gating Mechanism of Nicotinic Receptor Channel Revealed by Mutation Causing a Congenital Myasthenic Syndrome
  78. An Italian family with autosomal recessive quadriceps-sparing inclusion-body myopathy (ARQS-IBM) linked to chromosome 9p1
  79. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2
  80. Genetic Refinement and Physical Mapping of the CMT4B Gene on Chromosome 11q22
  81. Distal Hereditary Motor Neuronopathy of the Jerash Type
  82. Distal Hereditary Motor Neuronopathy of the Jerash Type
  83. Chromosome 17p-linked myasthenias stem from defects in the acetylcholine receptor  -subunit gene
  84. Medullary cystic kidney disease with hyperuricemia and gout in a large Cypriot family: No allelism with nephronophthisis type 1
  85. Congenital Myasthenic Syndrome (CMS) Type Ia: Clinical and Genetic Diversitya
  86. Chromosome 1 localization of a gene for autosomal dominant medullary cystic kidney disease
  87. Mapping of the familial infantile myasthenia (congenital myasthenic syndrome type Ia) gene to chromosome 17p with evidence of genetic homogeneity
  88. Genetic heterogeneity in adult dominant polycystic kidney disease in Cypriot families
  89. Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p
  90. Molecular genetic detection of Xp21 muscular dystrophy carriers in Cyprus
  91. Friedreich's ataxia phenotype not linked to chromosome 9 and associated with selective autosomal recessive vitamin E deficiency in two inbred Tunisian families
  92. New hereditary malformation syndrome of unusual facial appearance, skeletal deformities, and musculoskeletal and sensory defects
  93. Detection of Duchenne and Becker muscular dystrophy carriers by quantitative multiplex polymerase chain reaction analysis
  94. Weak Evidence for Allelic Association in the Cypriot PKD1 Population